Efatutazone and its Impurities

Efatutazone (also known as CS-7017 or inolitazone dihydrochloride) is an investigational oral drug that acts as a highly selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ). It is being studied for its potential antineoplastic (anticancer) activity in several types of cancers. Reference standards of Efatutazone API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.